XML 11 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 270.8 $ 289.2
Trade and other accounts receivable (less allowances of $9.8 million and $11.9 million respectively) 349.5 341.7
Inventories (less allowances of $39.4 million and $34.6 million respectively):    
Finished goods 236.3 197.9
Raw materials 108.9 103.1
Total inventories 345.2 301.0
Prepaid expenses 8.7 21.0
Prepaid income taxes 10.5 3.1
Other current assets 4.1 0.6
Total current assets 988.8 956.6
Net property, plant and equipment 278.6 269.7
Operating lease right-of-use assets 49.0 44.8
Goodwill 399.8 382.5
Other intangible assets 63.3 65.4
Deferred tax assets 8.9 9.4
Pension asset 0.0 2.4
Other non-current assets 11.0 3.9
Total assets 1,799.4 1,734.7
Current liabilities:    
Accounts payable 162.2 163.8
Accrued liabilities 167.3 169.1
Current portion of operating lease liabilities 16.0 13.9
Current portion of plant closure provisions 5.0 5.0
Accrued income taxes 5.6 19.6
Total current liabilities 356.1 371.4
Operating lease liabilities, net of current portion 33.0 31.0
Plant closure provisions, net of current portion 63.2 55.3
Deferred tax liabilities 14.1 23.5
Pension liabilities and post-employment benefits 13.8 13.1
Acquisition-related contingent consideration 8.2 20.1
Other non-current liabilities 8.1 4.2
Total liabilities 496.5 518.6
Equity:    
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares 0.3 0.3
Additional paid-in capital 373.6 369.9
Treasury stock (4,776,918 and 4,594,943 shares at cost, respectively) (115.3) (93.0)
Retained earnings 1,073.4 1,025.0
Accumulated other comprehensive loss (35.0) (91.0)
Total Innospec stockholders' equity 1,297.0 1,211.2
Non-controlling interest 5.9 4.9
Total equity 1,302.9 1,216.1
Total liabilities and equity $ 1,799.4 $ 1,734.7